Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox.

Kruger S, Schirle K, Haas M, Crispin A, Schirra J, Mayerle J, D'Haese JG, Kunz WG, Ricke J, Ormanns S, Kirchner T, Kobold S, Ilmer M, Gebauer L, Westphalen CB, von Bergwelt-Baildon M, Werner J, Heinemann V, Boeck S.

J Cancer Res Clin Oncol. 2019 Oct 23. doi: 10.1007/s00432-019-03061-4. [Epub ahead of print]

PMID:
31642961
2.

Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.

Ilmer M, Schiergens TS, Renz BW, Schneider C, Sargut M, Waligora R, Weniger M, Hartwig W, Ceyhan GO, Friess H, Werner J, D'Haese JG.

Surg Oncol. 2019 Aug 26;31:16-21. doi: 10.1016/j.suronc.2019.08.010. [Epub ahead of print]

PMID:
31473583
3.

Advances in cancer immunotherapy 2019 - latest trends.

Kruger S, Ilmer M, Kobold S, Cadilha BL, Endres S, Ormanns S, Schuebbe G, Renz BW, D'Haese JG, Schloesser H, Heinemann V, Subklewe M, Boeck S, Werner J, von Bergwelt-Baildon M.

J Exp Clin Cancer Res. 2019 Jun 19;38(1):268. doi: 10.1186/s13046-019-1266-0. Review.

4.

Repurposed Drugs in Pancreatic Ductal Adenocarcinoma: An Update.

Ilmer M, Westphalen CB, Niess H, DʼHaese JG, Angele MK, Werner J, Renz BW.

Cancer J. 2019 Mar/Apr;25(2):134-138. doi: 10.1097/PPO.0000000000000372. No abstract available.

PMID:
30896536
5.

β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer.

Renz BW, Takahashi R, Tanaka T, Macchini M, Hayakawa Y, Dantes Z, Maurer HC, Chen X, Jiang Z, Westphalen CB, Ilmer M, Valenti G, Mohanta SK, Habenicht AJR, Middelhoff M, Chu T, Nagar K, Tailor Y, Casadei R, Di Marco M, Kleespies A, Friedman RA, Remotti H, Reichert M, Worthley DL, Neumann J, Werner J, Iuga AC, Olive KP, Wang TC.

Cancer Cell. 2018 Nov 12;34(5):863-867. doi: 10.1016/j.ccell.2018.10.010. No abstract available.

6.

Cholinergic Signaling via Muscarinic Receptors Directly and Indirectly Suppresses Pancreatic Tumorigenesis and Cancer Stemness.

Renz BW, Tanaka T, Sunagawa M, Takahashi R, Jiang Z, Macchini M, Dantes Z, Valenti G, White RA, Middelhoff MA, Ilmer M, Oberstein PE, Angele MK, Deng H, Hayakawa Y, Westphalen CB, Werner J, Remotti H, Reichert M, Tailor YH, Nagar K, Friedman RA, Iuga AC, Olive KP, Wang TC.

Cancer Discov. 2018 Nov;8(11):1458-1473. doi: 10.1158/2159-8290.CD-18-0046. Epub 2018 Sep 5.

7.

β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer.

Renz BW, Takahashi R, Tanaka T, Macchini M, Hayakawa Y, Dantes Z, Maurer HC, Chen X, Jiang Z, Westphalen CB, Ilmer M, Valenti G, Mohanta SK, Habenicht AJR, Middelhoff M, Chu T, Nagar K, Tailor Y, Casadei R, Di Marco M, Kleespies A, Friedman RA, Remotti H, Reichert M, Worthley DL, Neumann J, Werner J, Iuga AC, Olive KP, Wang TC.

Cancer Cell. 2018 Jan 8;33(1):75-90.e7. doi: 10.1016/j.ccell.2017.11.007. Epub 2017 Dec 14. Erratum in: Cancer Cell. 2018 Nov 12;34(5):863-867.

8.

Avatars to personalized medicine: of mice and men.

Ilmer M, Berger M.

Hepatobiliary Surg Nutr. 2017 Oct;6(5):347-349. doi: 10.21037/hbsn.2017.06.05. No abstract available.

9.

Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs).

Renz BW, D'Haese JG, Werner J, Westphalen CB, Ilmer M.

Med Sci (Basel). 2017 Jun 19;5(2). pii: E14. doi: 10.3390/medsci5020014. Review.

10.

Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer.

Schiergens TS, Renz BW, Reu S, Neumann J, Al-Sayegh R, Nieß H, Ilmer M, Kruger S, Boeck S, Heinemann V, Werner J, Kleespies A.

J Gastrointest Surg. 2017 Nov;21(11):1775-1783. doi: 10.1007/s11605-017-3489-8. Epub 2017 Sep 5.

PMID:
28875420
11.

Therapeutic Innovations for Targeting Hepatoblastoma.

Garnier A, Ilmer M, Kappler R, Berger M.

Anticancer Res. 2016 Nov;36(11):5577-5592. Review.

PMID:
27793881
12.

Anesthetic and operative considerations for laparoscopic liver resection.

Egger ME, Gottumukkala V, Wilks JA, Soliz J, Ilmer M, Vauthey JN, Conrad C.

Surgery. 2017 May;161(5):1191-1202. doi: 10.1016/j.surg.2016.07.011. Epub 2016 Aug 18. Review.

PMID:
27545995
13.

Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells.

Ilmer M, Mazurek N, Gilcrease MZ, Byrd JC, Woodward WA, Buchholz TA, Acklin K, Ramirez K, Hafley M, Alt E, Vykoukal J, Bresalier RS.

Breast Cancer Res. 2016 Sep 29;18(1):97. doi: 10.1186/s13058-016-0757-6.

14.

Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics.

Ilmer M, Mazurek N, Byrd JC, Ramirez K, Hafley M, Alt E, Vykoukal J, Bresalier RS.

Cell Death Dis. 2016 Aug 11;7(8):e2337. doi: 10.1038/cddis.2016.239.

15.

The Analgesic Effect of the Mitochondria-Targeted Antioxidant SkQ1 in Pancreatic Inflammation.

Weniger M, Reinelt L, Neumann J, Holdt L, Ilmer M, Renz B, Hartwig W, Werner J, Bazhin AV, D'Haese JG.

Oxid Med Cell Longev. 2016;2016:4650489. doi: 10.1155/2016/4650489. Epub 2016 May 4.

16.

Role of N-acetylgalactosaminyltransferase 6 in early tumorigenesis and formation of metastasis.

Liesche F, Kölbl AC, Ilmer M, Hutter S, Jeschke U, Andergassen U.

Mol Med Rep. 2016 May;13(5):4309-14. doi: 10.3892/mmr.2016.5044. Epub 2016 Mar 24.

PMID:
27035742
17.

Truncated neurokinin-1 receptor is an ubiquitous antitumor target in hepatoblastoma, and its expression is independent of tumor biology and stage.

Garnier A, Ilmer M, Becker K, Häberle B, VON Schweinitz D, Kappler R, Berger M.

Oncol Lett. 2016 Jan;11(1):870-878. Epub 2015 Nov 20.

18.

JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells.

Recio-Boiles A, Ilmer M, Rhea PR, Kettlun C, Heinemann ML, Ruetering J, Vykoukal J, Alt E.

Oncotarget. 2016 Mar 1;7(9):9890-906. doi: 10.18632/oncotarget.7066.

19.

Pancreatic CSCs and microenvironment.

Ilmer M, Horst D.

Genes Cancer. 2015 Sep;6(9-10):365-6. No abstract available.

20.

Targeting the Neurokinin-1 Receptor Compromises Canonical Wnt Signaling in Hepatoblastoma.

Ilmer M, Garnier A, Vykoukal J, Alt E, von Schweinitz D, Kappler R, Berger M.

Mol Cancer Ther. 2015 Dec;14(12):2712-21. doi: 10.1158/1535-7163.MCT-15-0206. Epub 2015 Oct 29.

21.

Glycosyltransferases as Markers for Early Tumorigenesis.

Andergassen U, Liesche F, Kölbl AC, Ilmer M, Hutter S, Friese K, Jeschke U.

Biomed Res Int. 2015;2015:792672. doi: 10.1155/2015/792672. Epub 2015 Jun 16.

22.

Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells.

Garnier A, Vykoukal J, Hubertus J, Alt E, von Schweinitz D, Kappler R, Berger M, Ilmer M.

Int J Oncol. 2015 Jul;47(1):151-60. doi: 10.3892/ijo.2015.3016. Epub 2015 May 21.

PMID:
25998227
23.

Glycosyltransferases as marker genes for the quantitative polymerase chain reaction-based detection of circulating tumour cells from blood samples of patients with breast cancer undergoing adjuvant therapy.

Kölbl AC, Hiller RA, Ilmer M, Liesche F, Heublein S, Schröder L, Hutter S, Friese K, Jeschke U, Andergassen U.

Mol Med Rep. 2015 Aug;12(2):2933-8. doi: 10.3892/mmr.2015.3732. Epub 2015 May 5.

PMID:
25955084
24.

RSPO2 Enhances Canonical Wnt Signaling to Confer Stemness-Associated Traits to Susceptible Pancreatic Cancer Cells.

Ilmer M, Boiles AR, Regel I, Yokoi K, Michalski CW, Wistuba II, Rodriguez J, Alt E, Vykoukal J.

Cancer Res. 2015 May 1;75(9):1883-96. doi: 10.1158/0008-5472.CAN-14-1327. Epub 2015 Mar 13.

25.

Improved Method for Isolation of Neonatal Rat Cardiomyocytes with Increased Yield of C-Kit+ Cardiac Progenitor Cells.

Rutering J, Ilmer M, Recio A, Coleman M, Vykoukal J, Alt E.

J Stem Cell Res Ther. 2015;5(6):1-8.

26.

Benchtop isolation and characterization of functional exosomes by sequential filtration.

Heinemann ML, Ilmer M, Silva LP, Hawke DH, Recio A, Vorontsova MA, Alt E, Vykoukal J.

J Chromatogr A. 2014 Dec 5;1371:125-35.

PMID:
25458527
27.

Two sides of the same coin: stem cells in cancer and regenerative medicine.

Ilmer M, Vykoukal J, Recio Boiles A, Coleman M, Alt E.

FASEB J. 2014 Jul;28(7):2748-61. doi: 10.1096/fj.13-244640. Epub 2014 Mar 27. Review.

PMID:
24675364
28.

Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.

Berger M, Neth O, Ilmer M, Garnier A, Salinas-Martín MV, de Agustín Asencio JC, von Schweinitz D, Kappler R, Muñoz M.

J Hepatol. 2014 May;60(5):985-94. doi: 10.1016/j.jhep.2013.12.024. Epub 2014 Jan 8.

PMID:
24412605
29.

Detection and characterisation of disseminated tumour cells in bone marrow of breast cancer patients by immunostaining of Her-2 and MUC-1 in combination with Thomsen-Friedenreich (CD176).

Andergassen U, Kölbl AC, Zebisch M, Heublein S, Hutter S, Ilmer M, Schindlbeck C, Friese K, Jeschke U.

Histol Histopathol. 2014 Jul;29(7):913-23. doi: 10.14670/HH-29.913. Epub 2014 Jan 8.

PMID:
24399516
30.

Detection of breast cancer cells in blood samples by immunostaining of the Thomsen-Friedenreich antigen.

Andergassen U, Zebisch M, Kölbl AC, Schindlbeck C, Ilmer M, Hutter S, Heublein S, Rack B, Friese K, Jeschke U.

Future Oncol. 2013 May;9(5):747-52. doi: 10.2217/fon.13.24.

PMID:
23647302
31.

Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer—evaluation of several markers with real-time reverse transcription-PCR.

Andergassen U, Hofmann S, Kölbl AC, Schindlbeck C, Neugebauer J, Hutter S, Engelstädter V, Ilmer M, Friese K, Jeschke U.

Int J Mol Sci. 2013 Jan 8;14(1):1093-104. doi: 10.3390/ijms14011093.

32.

Quantification of breast cancer cells in peripheral blood samples by real-time rt-PCR.

Zebisch M, Kölbl AC, Schindlbeck C, Neugebauer J, Heublein S, Ilmer M, Rack B, Friese K, Jeschke U, Andergassen U.

Anticancer Res. 2012 Dec;32(12):5387-91.

PMID:
23225441
33.

Human osteoblast-derived factors induce early osteogenic markers in human mesenchymal stem cells.

Ilmer M, Karow M, Geissler C, Jochum M, Neth P.

Tissue Eng Part A. 2009 Sep;15(9):2397-409. doi: 10.1089/ten.tea.2008.0427.

PMID:
19292682
34.

Genital tuberculosis as the cause of tuboovarian abscess in an immunosuppressed patient.

Ilmer M, Bergauer F, Friese K, Mylonas I.

Infect Dis Obstet Gynecol. 2009;2009:745060. doi: 10.1155/2009/745060. Epub 2010 Mar 8.

35.

The Wnt signal transduction pathway in stem cells and cancer cells: influence on cellular invasion.

Neth P, Ries C, Karow M, Egea V, Ilmer M, Jochum M.

Stem Cell Rev. 2007 Jan;3(1):18-29. Review.

PMID:
17873378

Supplemental Content

Support Center